MHC class II auto-antigen presentation is unconventional

被引:26
|
作者
Sadegh-Nasseri, Scheherazade [1 ]
Kim, AeRyon [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA
来源
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
关键词
auto-antigens; immunodominance; HLA-DR antigens; cathepsin sensitivity; extracellular processing; paralyzed DC; cell free antigen-processing system; LYSOSOMAL CYSTEINE PROTEASES; DIABETOGENIC T-CELLS; CATHEPSIN-S; HLA-DM; ANTIGEN PRESENTATION; MOUSE MODEL; PEPTIDE; INSULIN; MOLECULES; SELECTION;
D O I
10.3389/fimmu.2015.00372
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen presentation is highly critical in adoptive immunity. Only by interacting with antigens presented by major histocompatibility complex class II molecules, helper T cells can be stimulated to fight infections or diseases. The degradation of a full protein into small peptide fragments bound to class II molecules is a dynamic, lengthy process consisting of many steps and chaperons. Deregulation in any step of antigen processing could lead to the development of self-reactive T cells or defective immune response to pathogens. Indeed, human leukocyte antigens class II genes are the predominant contributors to susceptibility to autoimmune diseases. Conventional antigen-processing calls for internalization of extracellular antigens followed by processing and epitope selection within antigen-processing subcellular compartments, enriched with all necessary accessory molecules, processing enzymes, and proper pH and denaturing conditions. However, recent data examining the temporal relationship between antigen uptakes, processing, and epitope selection revealed unexpected characteristics for auto-antigenic epitopes, which were not shared with antigenic epitopes from pathogens. This review provides a discussion of the relevance of these findings to the mechanisms of autoimmunity.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [1] Antigen presentation by MHC class II molecules
    Weenink, SM
    Gautam, AM
    IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (01): : 69 - 81
  • [2] MHC class II restricted antigen presentation
    Pieters, J
    CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 89 - 96
  • [3] Diversity in MHC class II antigen presentation
    Robinson, JH
    Delvig, AA
    IMMUNOLOGY, 2002, 105 (03) : 252 - 262
  • [4] Antigen presentation by MHC class I and II molecules
    Neefjes, JJ
    IMMUNOBIOLOGY, 1996, 195 (4-5) : 456 - 460
  • [5] Influence of Salmonella on MHC class II antigen presentation
    Jackson, N.
    Kang, Y. H.
    Lapaque, N.
    Janssen, H.
    Trowsdale, J.
    Kelly, A. P.
    IMMUNOLOGY, 2012, 137 : 478 - 478
  • [6] Viral inhibition of MHC class II antigen presentation
    Hegde, NR
    Chevalier, MS
    Johnson, DC
    TRENDS IN IMMUNOLOGY, 2003, 24 (05) : 278 - 285
  • [7] The endogenous pathway of MHC class II antigen presentation
    Lechler, R
    Aichinger, G
    Lightstone, L
    IMMUNOLOGICAL REVIEWS, 1996, 151 : 51 - 79
  • [8] Proteases involved in MHC class II antigen presentation
    Villadangos, JA
    Bryant, RAR
    Deussing, J
    Driessen, C
    Lennon-Duménil, AM
    Riese, RJ
    Roth, W
    Saftig, P
    Shi, GP
    Chapman, HA
    Peters, C
    Ploegh, HL
    IMMUNOLOGICAL REVIEWS, 1999, 172 : 109 - 120
  • [9] Routes to manipulate MHC class II antigen presentation
    van den Hoorn, Tineke
    Paul, Petra
    Jongsma, Marlieke L. M.
    Neefjes, Jacques
    CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (01) : 88 - 95
  • [10] Proteolysis and antigen presentation by MHC class II molecules
    Bryant, PW
    Lennon-Duménil, AM
    Fiebiger, E
    Lagaudrière-Gesbert, C
    Ploegh, HL
    ADVANCES IN IMMUNOLOGY, VOL 80, 2002, 80 : 71 - 114